A team of researchers used a new technique, called high-resolution template matching, or HRTM, to uncover in unprecedented detail the movement of ribosomes -- the molecular structures that synthesize ...
In a week marked by cautious Federal Reserve commentary and political uncertainty, global markets experienced significant fluctuations with U.S. stocks declining broadly before a late-week rally.
D Molecular Therapeutics Inc (FDMT) stock saw a modest uptick, ending the day at $6.31 which represents a slight increase of $0.53 or 9.17% from the prior close of $5.78. The stock opened at $5.8 and ...